BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MedImmune, LLC 

319 North Bernardo Avenue

Mountain View  California  94043  U.S.A.
Phone: 650-919-6598 Fax: n/a


SEARCH JOBS


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

Last Updated: 07-10-2008

 Key Statistics


Email:
Ownership: Subsidiary

Web Site: MedImmune, LLC
Employees: 2500
Symbol: 
 



Industry
Biotechnology






 Company News
Micromet Buys Out MedImmune, LLC's Remaining Rights to Blinatumomab 11/5/2009 8:59:51 AM    More...
Fourteen Abstracts Featuring MedImmune, Inc.'s Influenza and RSV Therapeutic Areas to Be Presented 4/29/2008 7:16:44 AM    More...
Desperate But Not Crazy 4/1/2008 1:13:51 PM    More...
MedImmune, Inc. Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis 11/26/2007 8:18:06 AM    More...
AstraZeneca PLC (AZN) Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Group PLC  (CATG) Into MedImmune, Inc. 10/29/2007 7:35:03 AM    More...
MedImmune, Inc. (MEDI) Founder, Wayne T. Hockmeyer, Ph.D., Retires 6/19/2007 1:34:28 PM    More...
MedImmune, Inc. (MEDI) Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013 6/19/2007 10:15:40 AM    More...
MedImmune, Inc. (MEDI) is Awarded Contract by U.S. Department of Health and Human Services to Retrofit Manufacturing Facilities for Production of Pandemic Influenza Vaccines 6/15/2007 12:44:48 PM    More...
MedImmune, Inc. (MEDI) Wins Stevie(R) Award at 5th Annual American Business Awards(SM) 6/12/2007 1:13:01 PM    More...
Infinity Pharmaceuticals, Inc. and MedImmune, Inc. (MEDI) Present Updated Phase I Results of IPI-504 in GIST at American Society of Clinical Oncology Annual Meeting 6/5/2007 1:31:09 PM    More...
123456789